Evidence map›Paper›PMID 30881450›Full record

ArticleAdvances in pharmacological sciences2019

Analysis of

Sandra J Gutiérrez-Prieto, Sandra J Perdomo-Lara, José M Diaz-Peraza, Luis Gonzalo Sequeda-Castañeda

Open access · goldAbstract read
In one paragraph

Article in Advances in pharmacological sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Frontiers in bioengineering and biotechnology · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Sandra J Gutiérrez-PrietoDental Research Center, School of Dentistry, Pontificia Universidad Javeriana, Bogotá, Colombia.ORCID 0000-0002-2112-2563
Sandra J Perdomo-LaraBasic Oral Research Unit, School of Dentistry, Universidad El Bosque, Bogotá, Colombia.ORCID 0000-0002-4429-3760
José M Diaz-PerazaDepartment of Physics, School of Sciences, Universidad Nacional de Colombia, Bogotá, Colombia.ORCID 0000-0002-3740-2594
Luis Gonzalo Sequeda-CastañedaDepartment of Chemistry, School of Sciences, Pontificia Universidad Javeriana, Bogotá, Colombia.ORCID 0000-0002-1639-1988
Pontificia Universidad Javeriana · COUniversidad El Bosque · COUniversidad Nacional de Colombia · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the main focuses of tissue engineering is to search for tridimensional scaffold materials, complying with nature's properties for tissue regeneration. Determining material biocompatibility is a fundamental step in considering its use. Therefore, the purpose of this study was to analyze osteoblast cell adhesion and viability on different materials to determine which was more compatible for future bone regeneration. Tridimensional structures were fabricated with hydroxyapatite, collagen, and porous silica. The bovine bone was used as material control. Biocompatibility was determined by seeding primary osteoblasts on each tridimensional structure. Cellular morphology was assessed by SEM and viability through confocal microscopy. Osteoblast colonization was observed on all evaluated materials' surface, revealing they did not elicit osteoblast cytotoxicity. Analyses of four different materials studied with diverse compositions and characteristics showed that adhesiveness was best seen for HA and viability for collagen. In general, the results of this investigation suggest these materials can be used in combination, as scaffolds intended for bone regeneration in dental and medical fields.

Identifiers

PMID30881450
PMCPMC6381563
OpenAlexW2914093379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.